EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The effect of the agonist Ac-RYRWK-NH2 and the antagonist Gly2nociceptin



The effect of the agonist Ac-RYRWK-NH2 and the antagonist Gly2nociceptin



Society for Neuroscience Abstracts 24(1-2): 1358




(PDF emailed within 1 workday: $29.90)

Accession: 033785331

Download citation: RISBibTeXText



Related references

The effect of the agonist-Ac-RYYRWKNH2 and the antagonist Gly2nociceptin. British Journal of Pharmacology 125(PROC SUPPL ): 5P, 1998

Nociceptin and its putative agonist -Gly2nociceptin. Neuroimmunomodulation 10(1): 71, August, 2002-, 2003

In vitro agonist effects of nociceptin and Gly2nociceptin. European Journal of Pharmacology 385(2-3): 217-223, Dec 3, 1999

The ORL1-receptor antagonist Gly2nociceptin. British Journal of Pharmacology 126(PROC SUPPL ): 142P, March, 1999

Nociceptin and the putative ORL1 antagonist Gly2nociceptin. British Journal of Pharmacology 126(PROC SUPPL ): 268P, March, 1999

In vitro characterization of agonist, antagonist, inverse agonist and agonist/antagonist benzodiazepines. Progress in Neuro-Psychopharmacology & Biological Psychiatry 8(4-6): 785-788, 1984

The affinity ratio for antagonist and agonist labeled binding sites predicts muscarinic receptor agonist antagonist action in central and peripheral tissues. Society for Neuroscience Abstracts 13(1): 487, 1987

Using the opioid antagonist naloxone and the agonist antagonist nalbuphine to eliminate the depressive effect of fentanyl during awakening. Vestnik Akademii Meditsinskikh Nauk SSSR (7): 13-17, 1991

Enhancement of excessive lever-pressing after post-training signal attenuation in rats by repeated administration of the D1 antagonist SCH 23390 or the D2 agonist quinpirole, but not the D1 agonist SKF 38393 or the D2 antagonist haloperidol. Behavioral Neuroscience 115(6): 91-300, 2001

Enhancement of excessive lever-pressing after post-training signal attenuation in rats by repeated administration of the D1 antagonist SCH 23390 or the D2 agonist quinpirole, but not the D1 agonist SKF 38393 or the D2 antagonist haloperidol. Behavioral Neuroscience 115(6): 1291-1300, 2002

Lack of substantial effect of the H3-antagonist thioperamide and of the non-selective mixed H3-antagonist/H1-agonist betahistine on amygdaloid kindled seizures. Epilepsy Research 40(2-3): 141-145, July, 2000

Effect of an opiate antagonist (naloxone) and an agonist/antagonist (nalbuphine) in primate hemorrhagic shock: relationship to catecholamine release. Circulatory Shock 17(4): 313-325, 1985

Opioid dipeptide derivatives with a mixed mu agonist/delta antagonist, partial mu agonist/delta antagonist or mu agonist/partial delta agonist profile. Fields, Gregg B [Author], Tam, James P [Author], Barany, George [Author] Peptides for the new millennium 229-230, 2000